NCT06156306 is a NA clinical trial of CBT-I in Insomnia, sponsored by Chinese University of Hong Kong.

Who is sponsoring NCT06156306?

NCT06156306 is sponsored by Chinese University of Hong Kong.

What drugs are being tested in NCT06156306?

Interventions in NCT06156306: CBT-I, CBT-I combined ACT.

What condition does NCT06156306 study?

NCT06156306 studies Insomnia, Anxiety, Youth.

Is NCT06156306 still recruiting?

NCT06156306 is currently recruiting now. Last updated 10 July 2025.

Last reviewed 2025-07-10 · How we verify

NCT06156306

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CBT-I Versus CBT-I+ACT for Youths With Insomnia and Anxiety

Recruiting now NA Last updated 10 July 2025

What this trial tests

NA trial testing CBT-I in Insomnia in 50 participants. Currently enrolling.

Timeline

15 December 2023

Primary endpoint
15 December 2025

31 December 2025

Quick facts

Lead sponsor	Chinese University of Hong Kong
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	50
Start date	15 December 2023
Primary completion	15 December 2025
Estimated completion	31 December 2025
Sites	1 location across Hong Kong

Drugs / interventions tested

CBT-I
CBT-I combined ACT

Conditions studied

Insomnia — all drugs for Insomnia →
Anxiety — all drugs for Anxiety →
Youth — all drugs for Youth →

Sponsor

Chinese University of Hong Kong

Who can join

Adults 15 to 24, any sex, with Insomnia or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Insomnia in adolescents and youth is a long-standing public health concern due to its high prevalence and association with various physical and mental health problems. Insomnia and psychiatric disorders are highly comorbid and intercorrelated in adolescents. Among all mental disorders, anxiety has been shown to be have high comorbidity with insomnia, affecting approximately 30% of individuals. CBT for insomnia (CBT-I) has been shown to be effective in improving sleep complaints and short-term improvement in mood while previous systematic reviews of interventional studies have demonstrated the effectiveness of acceptance and commitment therapy (ACT) interventions in treating insomnia, both as a primary condition and with other physical and/or mental health comorbidities. This study aims to compare the effect of CBT-I and CBT-I combined ACT in improving anxiety symptoms in youth.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of CBT-I

Trials testing the same drug.

NCT07333586 — Insomnia and Insulin Resistance · NA · not yet recruiting
NCT07279168 — Investigation of the Effectiveness of Virtual Reality (VR) Hypnosis in Improving Poor Sleep Among Chinese Childhood Canc · NA · not yet recruiting
NCT07091149 — Digital Cognitive Behavioral Treatment of Insomnia in Youth: An RCT Examining Feasibility, Acceptability, and Efficacy o · NA · recruiting
NCT06749444 — Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia · NA · recruiting
NCT06054243 — Efficacy of Group Cognitive Behavioural Therapy for Youth Anxiety and Insomnia · NA · recruiting

Other recruiting trials for Insomnia

Currently open trials in the same condition.

NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting
NCT07071324 — CF Wellness Program · NA · recruiting
NCT07417813 — A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders · recruiting
NCT06348082 — Project Women's Insomnia Sleep Health Equity Study (WISHES) · NA · recruiting

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

NCT07508644 — RSV Vaccination to Reduce Recurrent AECOPD · Phase 4 · not yet recruiting
NCT07230457 — Plasma MTB cfDNA Before Bronchoscopy · not yet recruiting
NCT07288671 — Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults · NA · not yet recruiting
NCT07256457 — Postoperative Pulmonary Function Assessment Based on Deep Learning Study · NA · not yet recruiting
NCT06904209 — Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06156306 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chinese University of Hong Kong
Last refreshed: 10 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06156306.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing